New Key Statistics Module, Z-Score and F-Score
SZSE:300584 Key Ratios
Market Cap ¥ M | 1,796.40 |
Enterprise Value ¥ M | 2,127.48 |
P/E(ttm) | 47.83 |
PE Ratio without NRI | 40.13 |
Forward PE Ratio | -- |
Price/Book | 1.79 |
Price/Sales | 3.55 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) ¥ M | 505.00 |
EPS (TTM) ¥ | 0.31 |
Beneish M-Score | -2.29 |
10-y EBITDA Growth Rate % | 8.40 |
5-y EBITDA Growth Rate % | -3.30 |
y-y EBITDA Growth Rate % | 37.50 |
EV-to-EBIT | 41.95 |
EV-to-EBITDA | 41.95 |
PEG | -- |
Shares Outstanding M | 120.00 |
Net Margin (%) | 7.42 |
Operating Margin % | 11.43 |
Pre-tax Margin (%) | 7.99 |
Quick Ratio | 0.68 |
Current Ratio | 0.91 |
ROA % (ttm) | 2.75 |
ROE % (ttm) | 3.83 |
ROIC % (ttm) | 4.34 |
Dividend Yield % | 0.33 |
Altman Z-Score | 3.79 |
SZSE:300584 Number of Guru Trades
SZSE:300584 Volume of Guru Trades
Gurus Latest Trades with SZSE:300584
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SZSE:300584 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Nanjing Hicin Pharmaceutical Co Ltd Insider Transactions
No Available Data